Avanos Medical AVNS Foreign currency translation
Foreign currency translation at other companies
Other financials
Where this comes from
Reported directly by Avanos Medical in its filing.
Tagged under the XBRL concept us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent.
The official record: Avanos Medical’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Avanos Medical's foreign currency translation.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Avanos Medical's foreign currency translation?
- Avanos Medical (AVNS) reported foreign currency translation of -$5.5M in Q1 2026.
- How has Avanos Medical's foreign currency translation changed year-over-year?
- Avanos Medical's foreign currency translation decreased by 339.1% year-over-year, from $2.3M to -$5.5M.
- What is the long-term trend for Avanos Medical's foreign currency translation?
- Over 3 years (2021 to 2025), Avanos Medical's foreign currency translation has grown at a 28.7% compound annual growth rate (CAGR), from -$6.1M to $13M.
- What does foreign currency translation mean?
- Measures the impact of translating the financial statements of foreign subsidiaries into the company's reporting currency. It reflects the volatility caused by exchange rate fluctuations on the value of international assets and liabilities.